RxDoctor Payments Data

Gail Mick

Pediatric Endocrinology · Birmingham, ALNPI 1306959523

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $116 of the $136 with a category attached, or 85.3%. 5 manufacturers reported payments, led by Abbott at 29.2% of the total. That places this record below the midpoint for pediatric endocrinology clinicians in AL, where the typical reported total is $944.

$136in general payments, 2019–2025

Across 8 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$40
  • Ferring Pharmaceuticals Inc.$37
  • Medtronic$25
  • Tolmar Pharmaceuticals, Inc.$20
  • Novo Nordisk$15
$392,089in research payments, 2019–2025

Across 616 payments — averaging $636.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurocrine Biosciences, Inc.$134K
  • Novo Nordisk AS$98K
  • Ascendis Pharma Endocrinology Inc$80K
  • Eli Lilly$79K

What the payments were for

  • Food & beverage$11685%
  • Education$2015%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$136 in reported general payments places this provider in the 10th percentile of 22 pediatric endocrinology providers in Alabama.

See all pediatric endocrinology providers in Alabama

Other pediatric endocrinology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →